2 most recent filings and news items mentioning ADPT. Updated every 60 seconds.
OfferingJun 22, 2026Neutral
Adaptive Biotechnologies Corporation entered into an indenture with U.S. Bank Trust Company for 0% convertible senior notes due 2031, dated June 22, 2026. This debt offering provides the company with capital financing while offering investors conversion rights to equity.
View filing at SEC.gov →
OfferingJun 15, 2026Positive
Adaptive Biotechnologies announced a proposed $250 million convertible senior notes offering to repay OrbiMed obligations and fund stock repurchases. Proceeds will enhance financial flexibility and support general corporate purposes and MRD business initiatives.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.